Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023868 · ClinicalTrials.gov registry record · Phase 3
Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)
A Phase 3 study, sponsored by American College of Radiology Imaging Network.
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00023868 is a Phase 3 study that was terminated before completion, run by American College of Radiology Imaging Network.
The verdict
NCT00023868, a Phase 3 study, was terminated before completion, sponsored by American College of Radiology Imaging Network.
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keeping chemotherapy drugs near the tumor. It is not yet known if chemoembolization is more effective than standard chemotherapy in treating metastatic cancer. PURPOSE: This phase I trial and randomized phase III trial is studying the effectiveness of chemoembolization in treating patients who have colorectal cancer metastatic to the liver.
Interventions
- DRUG cisplatin
- DRUG fluorouracil
- DRUG doxorubicin hydrochloride
- DRUG irinotecan hydrochloride
- DRUG FOLFIRI regimen
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-11-01 |
| Est. Completion | 2002-09-25 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00023868
The ClinicalTrials.gov registry entry for NCT00023868 describes a study currently listed as terminated, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is American College of Radiology Imaging Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00023868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00023868 about?
NCT00023868 is a clinical study titled "Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)". RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keep...
What is the current status of trial NCT00023868?
This trial is currently terminated. It is a Phase 3 study. The study started on 2001-11-01. Estimated completion is 2002-09-25.
What interventions are being tested in trial NCT00023868?
The interventions under investigation include: cisplatin (DRUG), fluorouracil (DRUG), doxorubicin hydrochloride (DRUG), irinotecan hydrochloride (DRUG), FOLFIRI regimen (DRUG).
Who is sponsoring clinical trial NCT00023868?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.